Cantor Equity Partners V Launches $200M IPO, Faces Dilution Concerns

TL;DR

**Avoid CEPV; the sponsor's near-zero cost basis and embedded fees create massive dilution and misaligned incentives, making it a high-risk bet for public shareholders.**

AI Summary

Cantor Equity Partners V, Inc. (CEPV) filed an S-1/A on October 14, 2025, for an initial public offering of 20,000,000 Class A ordinary shares at $10.00 per share, aiming to raise $200,000,000. The company is a blank check company, or SPAC, with no specific business combination target identified yet. The underwriters have a 45-day option to purchase an additional 3,000,000 Class A ordinary shares. Unlike some SPACs, this offering does not include warrants. CEPV has 24 months from the closing of the offering to complete an initial business combination, or it will redeem 100% of the Class A ordinary shares at the per-share trust account value. The sponsor, Cantor EP Holdings V, LLC, purchased 5,750,000 Class B ordinary shares for a nominal $25,000 (approximately $0.004 per share) and will also purchase 500,000 Class A ordinary shares for $5,000,000 in a private placement. Significant potential conflicts of interest exist due to the sponsor's low cost basis in founder shares and various fees payable to affiliates like Cantor Fitzgerald & Co., including a $4,000,000 underwriting discount and a $7,000,000 business combination marketing fee.

Why It Matters

This S-1/A filing signals Cantor Equity Partners V's intent to raise $200 million, providing a new SPAC vehicle for investors seeking exposure to future M&A. However, the significant dilution from the sponsor's $0.004 per share founder shares, coupled with potential conflicts of interest involving Cantor Fitzgerald & Co. and its affiliates, creates substantial risk for public shareholders. This structure is common in the SPAC market, but the explicit disclosure of these conflicts and the low cost basis for the sponsor's shares highlight a competitive landscape where sponsor incentives may not perfectly align with public investor returns. Investors need to weigh the potential for a lucrative business combination against the inherent structural disadvantages.

Risk Assessment

Risk Level: high — The risk level is high due to the substantial dilution public shareholders will face, as the sponsor acquired 5,750,000 Class B ordinary shares for only $25,000 (approximately $0.004 per share). This creates a strong incentive for the sponsor to complete any business combination, even if it's unprofitable for public shareholders, to realize a significant profit. Additionally, the filing explicitly states 'material conflicts of interest between our sponsor, its affiliates, our officers and directors... and purchasers in this offering,' further elevating risk.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the target business once identified, focusing on the valuation and terms of the business combination. Given the significant dilution and potential conflicts of interest, a 'wait and see' approach is advisable, avoiding pre-combination investment unless the target company presents an exceptionally compelling value proposition that clearly offsets the structural disadvantages.

Financial Highlights

revenue

$0

operating Margin

N/A

total Assets

$195,000,000

total Debt

$0

net Income

$0

eps

$0.00

gross Margin

N/A

cash Position

$195,000,000

revenue Growth

N/A

Key Numbers

• $200,000,000 — Target IPO proceeds (Amount to be raised from the sale of 20,000,000 Class A ordinary shares at $10.00 per share.)
• $10.00 — Public offering price per share (Price for each Class A ordinary share in the initial public offering.)
• 20,000,000 — Class A Ordinary Shares offered (Number of shares available in the initial public offering.)
• 3,000,000 — Over-allotment option shares (Additional Class A ordinary shares underwriters can purchase.)
• 24 months — Time to complete business combination (Deadline for the SPAC to complete its initial business combination.)
• $25,000 — Sponsor's purchase price for founder shares (Cost for 5,750,000 Class B ordinary shares, representing approximately $0.004 per share.)
• $0.004 — Per founder share cost (Nominal price paid by the sponsor for Class B ordinary shares, indicating significant dilution for public shareholders.)
• $5,000,000 — Sponsor's private placement purchase (Amount Cantor EP Holdings V, LLC will pay for 500,000 Class A ordinary shares.)
• $4,000,000 — Underwriting discount to CF&Co. (Fee payable to Cantor Fitzgerald & Co. upon closing of the IPO.)
• $7,000,000 — Business combination marketing fee to CF&Co. (Fee payable to Cantor Fitzgerald & Co. upon closing of the initial business combination.)

Key Players & Entities

• Cantor Equity Partners V, Inc. (company) — Registrant for S-1/A filing
• Cantor EP Holdings V, LLC (company) — Sponsor of Cantor Equity Partners V, Inc.
• Brandon G. Lutnick (person) — Chief Executive Officer of Cantor Equity Partners V, Inc.
• Douglas S. Ellenoff, Esq. (person) — Counsel from Ellenoff Grossman & Schole LLP
• Stuart Neuhauser, Esq. (person) — Counsel from Ellenoff Grossman & Schole LLP
• David Alan Miller, Esq. (person) — Counsel from Graubard Miller
• Jeffrey M. Gallant, Esq. (person) — Counsel from Graubard Miller
• U.S. Securities and Exchange Commission (regulator) — Regulatory body for S-1/A filing
• Cantor Fitzgerald & Co. (company) — Affiliate of sponsor, underwriter, and potential financial advisor
• Nasdaq Global Market (regulator) — Intended listing exchange for Class A ordinary shares

FAQ

Risk Factors

• SPAC Structure and Redemption Risk [high — financial]: CEPV is a blank check company with no identified target, posing a risk that it may not complete a business combination within the 24-month timeframe. Failure to do so will result in the redemption of 100% of Class A ordinary shares at the per-share trust account value, potentially leading to a complete loss of invested capital for public shareholders.
• Sponsor Dilution and Conflicts of Interest [high — financial]: The sponsor acquired 5,750,000 Class B shares for $25,000 ($0.004 per share), representing significant dilution to public shareholders who paid $10.00 per share. Additionally, the sponsor's purchase of 500,000 Class A shares for $5,000,000 in a private placement, coupled with substantial fees payable to affiliates like Cantor Fitzgerald & Co. ($4M underwriting, $7M business combination marketing fee), creates potential conflicts of interest.
• Lack of Business Combination Target [medium — financial]: As a SPAC, CEPV has not identified a specific business combination target. This lack of a defined strategy introduces uncertainty regarding the future value and success of the company post-IPO, as the target selection process is critical and subject to market conditions and negotiation.
• Dependence on Underwriter and Affiliate Fees [medium — financial]: The company is heavily reliant on Cantor Fitzgerald & Co. for underwriting and business combination marketing services, with significant fees ($4,000,000 underwriting discount and $7,000,000 business combination marketing fee) payable to this affiliate. This concentration of services and fees could impact the overall economics of the SPAC and potential target.
• SPAC Regulatory Scrutiny [medium — regulatory]: The SPAC market faces increasing regulatory scrutiny regarding disclosures, sponsor economics, and the process of business combinations. Changes in regulations or enforcement actions could impact CEPV's ability to complete a transaction or the valuation of its securities.

Industry Context

The SPAC market has experienced significant growth and subsequent contraction, with increased regulatory scrutiny. Companies like CEPV operate in a highly competitive environment where identifying and executing a successful business combination within a limited timeframe is challenging. The success of a SPAC is heavily dependent on the sponsor's ability to source attractive targets and negotiate favorable terms, while navigating market volatility and investor sentiment.

Regulatory Implications

CEPV is subject to SEC regulations governing IPOs and SPACs, including disclosure requirements and rules related to business combinations. The increasing focus on SPACs by regulators may lead to stricter compliance obligations and potential changes in the regulatory landscape, impacting the company's operations and the attractiveness of its securities.

What Investors Should Do

1. Scrutinize the sponsor's economics and potential conflicts of interest.
2. Evaluate the sponsor's track record and ability to identify a suitable business combination target.
3. Understand the implications of the redemption feature.
4. Assess the fees payable to affiliates.

Key Dates

• 2025-10-14: Filing of S-1/A — Initiated the IPO process for Cantor Equity Partners V, Inc., detailing the offering structure and terms.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that is created to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. (CEPV is structured as a SPAC, meaning its primary purpose is to find and merge with an operating company.)

Class A Ordinary Shares

The class of shares being offered to the public in the IPO. (These are the shares that public investors will purchase, entitling them to voting rights and a share of the company's assets and earnings.)

Class B Ordinary Shares

Shares held by the sponsor, Cantor EP Holdings V, LLC, which typically carry different voting rights and are subject to vesting or conversion conditions. (The low cost basis of these shares for the sponsor highlights potential dilution for public shareholders and associated conflicts of interest.)

Trust Account

A segregated account where the proceeds from the IPO are held in trust, typically invested in U.S. Treasury securities, until a business combination is completed or the SPAC liquidates. (The value in the trust account is the amount that public shareholders will receive if the SPAC fails to complete a business combination within the specified timeframe.)

Underwriting Discount

A fee paid by the issuing company to the underwriters for their services in marketing and selling the securities in an IPO. (Cantor Fitzgerald & Co. is set to receive a significant underwriting discount of $4,000,000.)

Business Combination Marketing Fee

A fee paid to an affiliate of the SPAC sponsor upon the successful completion of a business combination. (Cantor Fitzgerald & Co. is entitled to a $7,000,000 fee, which incentivizes the completion of a deal, potentially regardless of its long-term value.)

Redemption

The right of shareholders to have their shares repurchased by the company, typically at a specified price, often at the IPO price or trust account value. (Public shareholders have the right to redeem their shares if they do not approve of the business combination or if the SPAC liquidates.)

Year-Over-Year Comparison

As this is an S-1/A filing for an initial public offering, there is no prior year filing to compare against. Key metrics such as revenue, net income, and margins are not applicable at this pre-IPO stage. The filing primarily outlines the proposed offering structure, risks associated with SPACs, and the economics of the sponsor and underwriters.

Key Financial Figures

• $10.00 — s of Cantor Equity Partners V, Inc. for $10.00 per share. This Registration Statement
• $25,000 — tors — Our sponsor paid an aggregate of $25,000 for the founder shares, or approximatel
• $0.004 — or the founder shares, or approximately $0.004 per founder share, and, accordingly, yo
• $200,000,000 — TO COMPLETION, DATED OCTOBER 14, 2025 $200,000,000 Cantor Equity Partners V, Inc. 20,0
• $10,000 — tionally, we will reimburse our sponsor $10,000 per month for office space, administrat
• $50,000 — sh fees to our independent directors of $50,000 per year, payable quarterly, each as de
• $300,000 — n of this offering, we will repay up to $300,000 in loans made to us by our sponsor to c
• $1,750,000 — we will be obligated to repay the up to $1,750,000 loan commitment made by our sponsor for
• $4,000,000 — to receive an underwriting discount of $4,000,000 upon the closing of this offering, a bu
• $7,000,000 — a business combination marketing fee of $7,000,000 upon the closing of our initial busines
• $8,650,000 — initial business combination (or up to $8,650,000 if the underwriters' over -allotment op
• $230,000,000 — ivate placement shares, $200,000,000 or $230,000,000 if the underwriters' over -allotment op
• $1,000,000 — & Trust Company acting as trustee, and $1,000,000, together with $1,750,000 of additional

Filing Documents

• ea0253055-03.htm (S-1/A) — 5149KB
• ea025305503ex23-1_cantor1.htm (EX-23.1) — 2KB
• 0001213900-25-098721.txt ( ) — 8821KB
• ck0002034266-20251014.xsd (EX-101.SCH) — 10KB
• ck0002034266-20251014_def.xml (EX-101.DEF) — 16KB
• ck0002034266-20251014_lab.xml (EX-101.LAB) — 121KB
• ck0002034266-20251014_pre.xml (EX-101.PRE) — 73KB
• ea0253055-03_htm.xml (XML) — 1316KB

Risk Factors

Risk Factors 43 Cautionary Note Regarding Forward-Looking Statements 90

Use of Proceeds

Use of Proceeds 92 Dividend Policy 96

Dilution

Dilution 97 Capitalization 99

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 100 Proposed Business 107 Management 139 Principal Shareholders 151 Certain Relationships and Related Party Transactions 154

Description of Securities

Description of Securities 158 Taxation 173 Underwriting (Conflicts of Interest) 182 Legal Matters 192 Experts 192 Where You Can Find Additional Information 192 Index to Financial Statements F-1 We are responsible for the information contained in this prospectus. We have not authorized anyone to provide you with different information, and we take no responsibility for any other information others may give to you. We are not, and the underwriters are not, making an offer to sell securities in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Trademarks This prospectus contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the or symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies' trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. i Table of Contents SUMMARY This summary only highlights the more detailed information appearing elsewhere in this prospectus. You should read this entire prospectus carefully, including the information under the section of this prospectus entitled "Risk Factors" and our financial statements and the related notes included elsewhere in this prospectus, before investing. Unless otherwise stated in this prospectus, or the context otherwise requires, references to: " amended and restated memorandum and articles of association " are to the amended and restated memorandum and articles of association that we will adopt prior to the consummation

View Full Filing

View this S-1/A filing on SEC EDGAR